Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study

Kerry A. Rogers, MD, Michael A. Boxer, MD, Michael Y. Choi, MD, Richy Agajanian, MD, Donald M. Arnold, MD, Catherine M. Broome, MD, Joshua J. Field, MD, Irina Murakhovskaya, MD, Donna Chow, Robert P. Numerof, PhD, Hanzhe Zheng, PhD, Sandy Tong, MD, David J. Kuter

Blood (2019) 134 (Supplement_1): 3518.

https://doi.org/10.1182/blood-2019-126509

Published: 2019

Journal Articles

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study

David J. Kuter, MD DPhil, Richy Agajanian, MD, Donald M. Arnold, MD MSc, FRCPC, Michael Boxer, MD, Catherine Broome, MD, Joshua J. Field, MD, Irina Murakhovskaya, MD, Kerry A. Rogers, MD, Ann M Lowe, MD, Sandra Tong, MD, Hany Zayed, PhD, Anne-Marie Duliege, MD MS

Blood (2018) 132 (Supplement 1): 3612.

https://doi.org/10.1182/blood-2018-99-110483

Published: 2018

Journal Articles

Successful Treatment of Macrophage Activation Syndrome in Chronic Lymphoproliferative Disorder of Natural Killer Cells with Cyclophosphamide

Deepa Jeyakumar, MD, Sarmen Sarkissian, MD, Parwiz Siaghani, DO, Sherif Rezk, MD

Blood (2015) 126 (23): 5073.

https://doi.org/10.1182/blood.V126.23.5073.5073

Published: 2015

Journal Articles

Increased Incidence of Symptomatic Hyponatremia with Voriconazole Prophylaxis during Cyclophosphamide Based Conditioning in Patients Undergoing Hematopoietic Stem Cell Transplantation

Anant Gokarn, MD, Vikram Gota, MDPGDCT, Gautam Goyal, MDDM, Alok Gupta, MD, Sachin Punatar, MD DM, Pravin Patil, MSc, Krunal Kavathiya, MPharm, Kamal Pathak, Murari Gujjar, Libin Mathew, Bhausaheb Bagal, MD DM., Sadhana Kannan, MSc, Navin Khattry, MDDM

Blood (2014) 124 (21): 2467.

https://doi.org/10.1182/blood.V124.21.2467.2467

Published: 2014

Journal Articles

Neurological Complications in Stem Cell Transplantation of Childhood

Akihiro Iguchi, MD, PhD, Minako Sugiyama, MD, Yukayo Terashita, MD, Junjiro Ohshima, MD, PhD, Yuko Cho, MD, PhD, Tadashi Ariga, MD, PhD

Blood (2012) 120 (21): 4465.

https://doi.org/10.1182/blood.V120.21.4465.4465

Published: 2012

Journal Articles

Chemotherapy Toxicity Related to Non-Alcoholic Fatty Liver Disease (NAFLD) in an Adolescent with Pre-B Cell Acute Lymphoblastic Leukemia

Chatchawin Assanasen, MD, Rony Skaria, MD, Maria G. Falcon, MD, Victor Saldivar, MD

Blood (2012) 120 (21): 4303.

https://doi.org/10.1182/blood.V120.21.4303.4303

Published: 2012

Journal Articles

Implementation of An Aggressive Risk Stratified Treatment Protocol for Children and Adolescents with Acute Lymphoblastic Leukemia in a Developing Country

Samar A. Muwakkit, MD, Carol Al-Aridi, MD, Ahmad Samra, MD, Raya Saab, MD, Rami Mahfouz, MD, MPH, Chantal Farra, MD, Sima Jeha, MD, Miguel R. Abboud, MD

Blood (2011) 118 (21): 876.

https://doi.org/10.1182/blood.V118.21.876.876

Published: 2011

Journal Articles

Risk Factors of HHV6 Reactivation and Relationship Between Syndrome of Inappropriate Antidiuretic Hormone Secretion After Stem Cell Transplantation in Pediatric Patients

Ryoji Kobayashi, M.D., PhD, Naohisa Toriumi, M.D., Makoto Yoshida, M.D., Ph.D., Akihiro Iguchi, MD, PhD, Takeo Sarashina, M.D., Daisuke Suzuki, M.D., Ph.D., Hirozumi Sano, M.D., Masao Ogata, M.D.

Blood (2011) 118 (21): 4580.

https://doi.org/10.1182/blood.V118.21.4580.4580

Published: 2011

Journal Articles

RCHOP Therapy Overcome Gastric Diffuse Large B Cell Lymphoma without Surgery

Yuko Mishima, MD, Yasuhito Terui, MD, PhD, Masahiro Yokoyama, MD, Sakura Sakajiri, MD, PhD, Noriko Nishimura, MD, PhD, Kenji Nakano, MD, Eriko Nara, MD, Kazuhito Suzuki, MD, Kentaro Nasu, MD, Shunji Takahashi, MD, PhD, Kengo Takeuchi, MD, PhD, Kiyohiko Hatake, MD, PhD

Blood (2010) 116 (21): 1760.

https://doi.org/10.1182/blood.V116.21.1760.1760

Published: 2010

Journal Articles

Varialibility of Neurological Complications in the Treatment of Acute Lymphoblastic Leukemia:Experience of a Single Pediatric Institution

Rosanna Parasole, Fara Petruzziello, Nicoletta Marra, Luciano Marchese, Argia Mangione, Ernesto Cianciulli, Giuseppe Menna, Aldo Misuraca, Vincenzo Poggi

Blood (2008) 112 (11): 3939.

https://doi.org/10.1182/blood.V112.11.3939.3939

Published: 2008

Journal Articles

Incidence and Risk Factors for Developing Limbic Encephalitis in Allogeneic Stem Cell Transplantation.

Christopher D. Braden, DO, Patrick L. Alore, B.S., Patrick J. Stiff, M.D., Tulio E. Rodriguez, M.D., Mala Parthasarathy, M.S., Amir A. Toor, M.D., Micheal P. Macken, M.D.

Blood (2006) 108 (11): 2919.

https://doi.org/10.1182/blood.V108.11.2919.2919

Published: 2006

Journal Articles

Syndrome of Inappropriate Secretion of Anti-Diuretic Hormone in Children with Acute Lymphoblastic Leukemia.

Anupama S. Borker, MD, Sabrina Hutchins, MD, Robin Grant, Nobuko Hijiya, MD, John T. Sandlund, MD, Monika L. Metzger, MD, Sima Jeha, MD, Bassem I. Razzouk, MD, Raul C. Ribeiro, MD, Jeffrey E. Rubnitz, MD, Melissa M. Hudson, MD, Mary V. Relling, MD, Ching-Hon Pui, MD, Scott Howard, MD

Blood (2006) 108 (11): 4474.

https://doi.org/10.1182/blood.V108.11.4474.4474

Published: 2006

Journal Articles

A Phase II Study of Denileukin Diftitox (ONTAK R ) in Patients with Fludarabine Refractory B-Cell Chronic Lymphocytic Leukemia.

Philip Kuriakose, MD, Francesco Turturro, MD, Jesus G. Berdeja, MD, Robert Kerr, MD, Asha Surendranathan, Jennifer Black, Arthur E. Frankel, MD

Blood (2004) 104 (11): 4824.

https://doi.org/10.1182/blood.V104.11.4824.4824

Published: 2004

Journal Articles

The Efficacy and Long-Term Toxicity of Intravenous Busulfan and Cyclophosphamide Conditioning Regimen for Stem Cell Transplantation in Advanced Lymphoma.

Edgardo S. Santos, M.D., Teresa DeCesare, M.D., Mark Goodman, M.D., Joseph D. Rosenblatt, M.D., Denise L. Pereira, M.D., Hugo F. Fernandez, M.D.

Blood (2004) 104 (11): 5215.

https://doi.org/10.1182/blood.V104.11.5215.5215

Published: 2004

NARROW

Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study

Successful Treatment of Macrophage Activation Syndrome in Chronic Lymphoproliferative Disorder of Natural Killer Cells with Cyclophosphamide

Increased Incidence of Symptomatic Hyponatremia with Voriconazole Prophylaxis during Cyclophosphamide Based Conditioning in Patients Undergoing Hematopoietic Stem Cell Transplantation

Neurological Complications in Stem Cell Transplantation of Childhood

Chemotherapy Toxicity Related to Non-Alcoholic Fatty Liver Disease (NAFLD) in an Adolescent with Pre-B Cell Acute Lymphoblastic Leukemia

Implementation of An Aggressive Risk Stratified Treatment Protocol for Children and Adolescents with Acute Lymphoblastic Leukemia in a Developing Country

Risk Factors of HHV6 Reactivation and Relationship Between Syndrome of Inappropriate Antidiuretic Hormone Secretion After Stem Cell Transplantation in Pediatric Patients

RCHOP Therapy Overcome Gastric Diffuse Large B Cell Lymphoma without Surgery

Varialibility of Neurological Complications in the Treatment of Acute Lymphoblastic Leukemia:Experience of a Single Pediatric Institution

Incidence and Risk Factors for Developing Limbic Encephalitis in Allogeneic Stem Cell Transplantation.

Syndrome of Inappropriate Secretion of Anti-Diuretic Hormone in Children with Acute Lymphoblastic Leukemia.

A Phase II Study of Denileukin Diftitox (ONTAK R ) in Patients with Fludarabine Refractory B-Cell Chronic Lymphocytic Leukemia.

The Efficacy and Long-Term Toxicity of Intravenous Busulfan and Cyclophosphamide Conditioning Regimen for Stem Cell Transplantation in Advanced Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only